1-3 of 3
Anna Porwit
Close
Sort by
Journal Articles

CD163+ macrophages in mantle cell lymphoma induce activation of pro-survival pathways and immune suppression

Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Mostafa Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
Journal: Blood Advances
Blood Adv bloodadvances.2023012039.
https://doi.org/10.1182/bloodadvances.2023012039
Published: 2024
Includes: Supplemental data
Journal Articles

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma

Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, Mats Jerkeman, Anna Porwit, Daniel Molin, Gunilla Enblad, Arne Kolstad, Riikka Räty, Martin Hutchings, Caroline E. Weibull, Peter Hollander, Sara Ek, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5304–5313.
https://doi.org/10.1182/bloodadvances.2023010052
Published: 2023
Includes: Supplemental data
Journal Articles

The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study

Clinical Trials & Observations
Gudbjörg Jonsdottir, Sigrún H. Lund, Magnus Björkholm, Ingemar Turesson, Malin Hultcrantz, Anna Porwit, Yogesh S. Jethava, Ola Landgren, Sigurdur Y. Kristinsson
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2392–2398.
https://doi.org/10.1182/bloodadvances.2017007930
Published: 2017